PRIMALAN

This brand name is authorized in France, Tunisia

Active ingredients

The drug PRIMALAN contains one active pharmaceutical ingredient (API):

1 Mequitazine UNII Y463242LY2 - MEQUITAZINE

Mequitazine is a phenothiazine derivative with the actions and uses of antihistamines. Antihistamines diminish or abolish the main actions of histamine in the body by competitive, reversible blaockade of histamine receptor site on tissues; they do not inactivate histamine or prevent its synthesis or release. Antihistamines are used for palliative treatment of allergic reactions. Read about Mequitazine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PRIMALAN Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AD07	Mequitazine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AD Phenothiazine derivatives
Discover more medicines within R06AD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 63036718, 63209974, 66854318
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9043111, 9043112B, 9043113, 9323201, 9323202, 9323203